Semaglutide was approved by the FDA in 2017 for treating Type 2 diabetes, establishing its credibility as a treatment option
Specifically, we utilized the Annexin V-FITC Apoptosis Detection Kit (C1062S, Beyotime) according to the manufacturers instructions
Research confirms that concerns arise from notable reductions in lean mass, especially as they relate to metabolic adaptation and physical function
[PubMed] [Wiley] Ha SB, Smith AP, Howden R, Dietrich WM, Bugg S, OConnell MJ, Goldsbrough PB, Cobbett CS
Some patients report that cold injections feel slightly uncomfortable or produce more localized sting, but this is a sensory response only
Common reasons for treatment interruptions include: Medication supply shortages or availability issues Intolerable gastrointestinal side effects requiring a break Acute illness or surgical procedures Pregnancy or planning pregnancy (note: Wegovy must be discontinued at least 2 months before planned conception) Funding or prescription access changes Travel or lifestyle disruptions Recognising why the interruption occurred helps inform the restart strategy and prevents future discontinuations
